Lucid Group is delighted to announce that Managing Director Simon Bates has been appointed Chair of the PMEA (Pharmaceutical Market Excellence Awards) judging panel.
Widely regarded as one of the healthcare industry’s most prestigious awards programmes, the PMEAs celebrate excellence in market excellence strategy, innovation, and partnership across the pharmaceutical, biotech, and medtech sectors. As Chair, Simon will lead the judging panel and help shape the evaluation process that recognises the organisations, teams, and initiatives delivering meaningful impact across healthcare.
As Managing Director of Lucid Group Strategy Consulting, Simon brings extensive experience to the role, having supported the PMEAs as both a judge and steering group member over several years. His appointment reflects a long-standing commitment to advancing excellence across the life sciences industry and championing the innovation and collaboration that drive better outcomes for patients and healthcare systems.
Commenting on his appointment, Simon said:
“I am honoured to take on the role of Chair. The PMEAs are the life sciences industry’s leading awards programme, celebrating and promoting the best Market Excellence strategies from pharma, biotech and medtech, and especially these companies’ innovation and commitment to partnering with healthcare providers, payers, charities and related organisations.”
The 2026 PMEA Awards programme, brings together leaders from across the life sciences industry to celebrate the strategies, partnerships, and initiatives shaping the future of healthcare.
Read the full announcement here: https://pmlive.com/pmea-welcome-simon-bates-as-new-chair-of-the-judging-panel/
About Lucid Group
Lucid Group translates bold science into market impact, fused by scientific, strategic, commercial, creative, and human expertise, powered by our real-world data platform, to uncover the Lucid Truth: governing insights into what must shift for an asset to be adopted. Through bold, behaviour-changing interventions, Lucid helps clients drive outstanding commercial performance and meaningful patient impact.